Sino Biopharmaceutical Limited announced that "Linezolid and Glucose Injection" (brand name:Yi Rui Da) (specifications: 100ml and 300ml), an anti-infectious drug of the Group, has obtained the notice of approval of supplemental applications issued by the National Medical Products Administration of the People's Republic of China, and has passed the Consistency of Quality and Efficacy Evaluation for Generic Drugs (the "Consistency Evaluation"), being one of the first batch of its kind to pass the Consistency Evaluation in China.